The hospital knew that not taking medications as prescribed following discharge is one of the major drivers of readmissions, so it knew it needed a way to proactively manage this risk and improve its ...

Over the past decade, healthcare organizations (HCOs) have relied on radio frequency identification (RFID) solutions to assist with patient identification and monitoring, as well as asset tracking.

A quartet of med-tech pros has established a new venture capital firm that promises to shake up the investment world. Known as Engage Venture Partners, the Minneapolis-based firm plans to invest in ...

Telehealth staffing and tech services startup Wheel is teaming up with drug discount app GoodRx to integrate real-time pricing and discounts on medication at the point of care. Austin, Texas-based ...

Moby summary of AngioDynamics, Inc.'s Q3 2026 earnings call ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...

The strong performance was driven by the company’s mechanical thrombectomy portfolio, including AlphaVac and AngioVac, which grew 17.9%, while Auryon sales increased 17.9% and NanoKnife sales jumped ...

Pharmacies and providers are turning to AI to better understand why their patients aren’t following doctors’ orders on their prescriptions. Like pretty much all of AI, ambient tools are evolving at a ...

Minnesota’s reputation for starting and building medical-technology companies has been earned over decades; less known is that the unassuming suburb of Plymouth has become the epicenter of the ...

New Hampshire lawmakers are weighing a measure to funnel state funding to skilled nursing facilities that train employees as medication nursing assistants. The goal is to increase certifications for ...

Baird analysts outlined stocks within medical technology where they see an upside during the second quarter’s earnings. Healthcare and med-tech has underperformed the broader market year-to-date, but ...